What company does Kathy Yi work for?

Kathy Yi is a Chief Financial Officer at Cerevel Therapeutics, a company specializing in Biological products, except diagnostic.

Where Kathy Yi graduated from?

Kathy Yi holds a degree in Bachelor Of Science from University of California, Berkeley.

Who is Kathy Yi?

Kathy Yi is a seasoned biotech executive with extensive experience in financial leadership and corporate development within the pharmaceutical and semiconductor industries. Currently serving as the Chief Operating Officer at Affini T Therapeutics and a board member at both Theseus Pharmaceuticals and Transition Bio, she has a proven track record in mergers and acquisitions, strategic financial planning, and cross-functional team leadership. Kathy's educational background includes an MBA in Finance from Columbia Business School and a BS in Chemical Engineering from UC Berkeley. She has held senior roles at prominent companies such as Cerevel Therapeutics and Novartis, demonstrating her ability to navigate complex organizational structures and drive growth. Her expertise in financial analysis and corporate finance positions her as a key player in shaping the future of biotech innovation. Kathy is passionate about leveraging her skills to foster advancements in healthcare and improve patient outcomes.